Safety of a heat-stable rotavirus vaccine among children in Niger: Data from a phase 3, randomized, double-blind, placebo-controlled trial

Hdl Handle:
http://hdl.handle.net/10144/619161
Title:
Safety of a heat-stable rotavirus vaccine among children in Niger: Data from a phase 3, randomized, double-blind, placebo-controlled trial
Authors:
Coldiron, ME; Guindo, O; Makarimi, R; Soumana, I; Matar Seck, A; Garba, S; Macher, E; Isanaka, S; Grais, RF
Journal:
Vaccine
Abstract:
Rotavirus remains a major cause of diarrhea among children under 5 years of age. The efficacy of RotaSIIL, a pentavalent rotavirus vaccine, was shown in an event-driven trial in Niger. We describe the two-year safety follow-up of this trial.
Publisher:
Elsevier
Issue Date:
8-May-2018
URI:
http://hdl.handle.net/10144/619161
DOI:
10.1016/j.vaccine.2018.05.023
PubMed ID:
29752026
Additional Links:
http://www.sciencedirect.com/science/journal/0264410X
Submitted date:
2018-05-18
Language:
en
ISSN:
1873-2518
Appears in Collections:
Vaccination

Full metadata record

DC FieldValue Language
dc.contributor.authorColdiron, MEen
dc.contributor.authorGuindo, Oen
dc.contributor.authorMakarimi, Ren
dc.contributor.authorSoumana, Ien
dc.contributor.authorMatar Seck, Aen
dc.contributor.authorGarba, Sen
dc.contributor.authorMacher, Een
dc.contributor.authorIsanaka, Sen
dc.contributor.authorGrais, RFen
dc.date.accessioned2018-05-22T14:55:57Z-
dc.date.available2018-05-22T14:55:57Z-
dc.date.issued2018-05-08-
dc.date.submitted2018-05-18-
dc.identifier.citationSafety of a heat-stable rotavirus vaccine among children in Niger: Data from a phase 3, randomized, double-blind, placebo-controlled trial. 2018 Vaccineen
dc.identifier.issn1873-2518-
dc.identifier.pmid29752026-
dc.identifier.doi10.1016/j.vaccine.2018.05.023-
dc.identifier.urihttp://hdl.handle.net/10144/619161-
dc.description.abstractRotavirus remains a major cause of diarrhea among children under 5 years of age. The efficacy of RotaSIIL, a pentavalent rotavirus vaccine, was shown in an event-driven trial in Niger. We describe the two-year safety follow-up of this trial.en
dc.language.isoenen
dc.publisherElsevieren
dc.relation.urlhttp://www.sciencedirect.com/science/journal/0264410Xen
dc.rightsPublished by Elsevier Archived on this site with kind permission and copyright 200X from Elsevieren
dc.titleSafety of a heat-stable rotavirus vaccine among children in Niger: Data from a phase 3, randomized, double-blind, placebo-controlled trialen
dc.identifier.journalVaccineen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.